Neuroproteomics / / Angus C. Nairn, Kenneth R. Williams.

The Neuroproteomics Special Issue overviews the unique challenges that must be addressed to carry out meaningful MS/proteomics analyses on neural tissues and the technologies that are available to meet these challenges. The articles on Alzheimer's disease, addiction, and schizophrenia illustrat...

Full description

Saved in:
Bibliographic Details
VerfasserIn:
TeilnehmendeR:
Place / Publishing House:Basel : : MDPI - Multidisciplinary Digital Publishing Institute,, 2020.
Year of Publication:2020
Language:English
Physical Description:1 online resource (318 pages) :; illustrations
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993602806104498
ctrlnum (CKB)4100000011302091
(NjHacI)994100000011302091
(EXLCZ)994100000011302091
collection bib_alma
record_format marc
spelling Nairn, Angus C., author.
Neuroproteomics / Angus C. Nairn, Kenneth R. Williams.
Basel : MDPI - Multidisciplinary Digital Publishing Institute, 2020.
1 online resource (318 pages) : illustrations
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on publisher supplied metadata and other sources.
The Neuroproteomics Special Issue overviews the unique challenges that must be addressed to carry out meaningful MS/proteomics analyses on neural tissues and the technologies that are available to meet these challenges. The articles on Alzheimer's disease, addiction, and schizophrenia illustrate how MS/proteomics technologies can be used to improve our ability to diagnose and understand the molecular basis for neurological diseases. Several articles will be of interest to investigators beyond the field of neurological disorders. The review on the discovery of biofluid biomarkers of neurodegenerative dementias will be of interest to investigators searching for other disease biomarkers. Similarly, the review on the role of neuroproteomics in elucidating mechanisms of drug addiction provides an overview of the utility of MS/proteomics approaches for addressing critical questions in addiction neuroscience that should be applicable to investigators involved in virtually any area of biomedical research. Likewise, the article on developing targeted MS approaches for quantifying postsynaptic density proteins will be useful for any investigator who wishes to design targeted assays for virtually any protein. Finally, the peroxidase-mediated proximity labeling technology, described in the article on mapping the proteome of the synaptic cleft, will be of interest to investigators interested in mapping other spatially restricted proteomes.
English.
Proteomics.
3-03928-106-2
Williams, Kenneth R., author.
language English
format eBook
author Nairn, Angus C.,
Williams, Kenneth R.,
spellingShingle Nairn, Angus C.,
Williams, Kenneth R.,
Neuroproteomics /
author_facet Nairn, Angus C.,
Williams, Kenneth R.,
Williams, Kenneth R.,
author_variant a c n ac acn
k r w kr krw
author_role VerfasserIn
VerfasserIn
author2 Williams, Kenneth R.,
author2_role TeilnehmendeR
author_sort Nairn, Angus C.,
title Neuroproteomics /
title_full Neuroproteomics / Angus C. Nairn, Kenneth R. Williams.
title_fullStr Neuroproteomics / Angus C. Nairn, Kenneth R. Williams.
title_full_unstemmed Neuroproteomics / Angus C. Nairn, Kenneth R. Williams.
title_auth Neuroproteomics /
title_new Neuroproteomics /
title_sort neuroproteomics /
publisher MDPI - Multidisciplinary Digital Publishing Institute,
publishDate 2020
physical 1 online resource (318 pages) : illustrations
isbn 3-03928-106-2
callnumber-first Q - Science
callnumber-subject QP - Physiology
callnumber-label QP551
callnumber-sort QP 3551 N357 42020
illustrated Illustrated
dewey-hundreds 500 - Science
dewey-tens 570 - Life sciences; biology
dewey-ones 572 - Biochemistry
dewey-full 572.6
dewey-sort 3572.6
dewey-raw 572.6
dewey-search 572.6
work_keys_str_mv AT nairnangusc neuroproteomics
AT williamskennethr neuroproteomics
status_str n
ids_txt_mv (CKB)4100000011302091
(NjHacI)994100000011302091
(EXLCZ)994100000011302091
carrierType_str_mv cr
is_hierarchy_title Neuroproteomics /
author2_original_writing_str_mv noLinkedField
_version_ 1796653186050686976
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02476nam a2200313 i 4500</leader><controlfield tag="001">993602806104498</controlfield><controlfield tag="005">20230627184841.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230627s2020 sz a o 000 0 eng d</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/books978-3-03928-107-7</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4100000011302091</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994100000011302091</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994100000011302091</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QP551</subfield><subfield code="b">.N357 2020</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">572.6</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Nairn, Angus C.,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Neuroproteomics /</subfield><subfield code="c">Angus C. Nairn, Kenneth R. Williams.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">2020.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (318 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The Neuroproteomics Special Issue overviews the unique challenges that must be addressed to carry out meaningful MS/proteomics analyses on neural tissues and the technologies that are available to meet these challenges. The articles on Alzheimer's disease, addiction, and schizophrenia illustrate how MS/proteomics technologies can be used to improve our ability to diagnose and understand the molecular basis for neurological diseases. Several articles will be of interest to investigators beyond the field of neurological disorders. The review on the discovery of biofluid biomarkers of neurodegenerative dementias will be of interest to investigators searching for other disease biomarkers. Similarly, the review on the role of neuroproteomics in elucidating mechanisms of drug addiction provides an overview of the utility of MS/proteomics approaches for addressing critical questions in addiction neuroscience that should be applicable to investigators involved in virtually any area of biomedical research. Likewise, the article on developing targeted MS approaches for quantifying postsynaptic density proteins will be useful for any investigator who wishes to design targeted assays for virtually any protein. Finally, the peroxidase-mediated proximity labeling technology, described in the article on mapping the proteome of the synaptic cleft, will be of interest to investigators interested in mapping other spatially restricted proteomes.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Proteomics.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03928-106-2</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Williams, Kenneth R.,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-07-08 12:11:02 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2020-06-20 22:16:43 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338832290004498&amp;Force_direct=true</subfield><subfield code="Z">5338832290004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338832290004498</subfield></datafield></record></collection>